Cardiovascular complications of coronavirus disease-2019

CM Terzic, BJ Medina-Inojosa - Physical Medicine and …, 2023 - pmr.theclinics.com
In the initial 3 years of the pandemic, the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the etiologic agent of coronavirus disease-2019 (COVID-19), has infected …

The intriguing role of TLR accessory molecules in cardiovascular health and disease

T Bezhaeva, J Karper, PHA Quax… - Frontiers in …, 2022 - frontiersin.org
Activation of Toll like receptors (TLR) plays an important role in cardiovascular disease
development, progression and outcomes. Complex TLR mediated signaling affects vascular …

Long COVID clinical phenotypes up to 6 months after infection identified by latent class analysis of self-reported symptoms

M Gottlieb, ES Spatz, H Yu, LE Wisk… - Open forum …, 2023 - academic.oup.com
Background The prevalence, incidence, and interrelationships of persistent symptoms after
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary. There are …

Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern

SD Tyrkalska, A Martínez-López, AB Arroyo… - Science …, 2022 - science.org
The coronavirus disease 2019 (COVID-19) pandemic turned the whole world upside down
in a short time. One of the main challenges faced has been to understand COVID-19 …

Musculoskeletal manifestations of COVID-19

LNM da Silva, AGO Filho, JB Guimarães - Skeletal Radiology, 2024 - Springer
During the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infected millions of people worldwide, with acute respiratory distress syndrome …

Vascular function, systemic inflammation, and Coagulation activation 18 Months after COVID-19 infection: an observational cohort study

LH Willems, LMC Jacobs, LA Groh, H Ten Cate… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Among its effect on virtually all other organs, COVID-19 affects the
cardiovascular system, potentially jeopardizing the cardiovascular health of millions …

Potential clinical applications of phytopharmaceuticals for the in‐patient management of coagulopathies in COVID‐19

AK Mukherjee, DJ Chattopadhyay - Phytotherapy Research, 2022 - Wiley Online Library
Thrombotic complications occur in many cardiovascular pathologies and have been
demonstrated in COVID‐19. The currently used antithrombotic drugs are not free of adverse …

SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection

A Richards, AS Khalil, M Friesen, TW Whitfield… - Nature …, 2024 - nature.com
Although respiratory symptoms are the most prevalent disease manifestation of infection by
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), nearly 20% of …

[HTML][HTML] A pictorial essay describing the CT imaging features of COVID-19 cases throughout the pandemic with a special focus on lung manifestations and …

B Brogna, E Bignardi, A Megliola, A Laporta… - Biomedicines, 2023 - mdpi.com
With the Omicron wave, SARS-CoV-2 infections improved, with less lung involvement and
few cases of severe manifestations. In this pictorial review, there is a summary of the …

SARS‐CoV‐2 spike protein induces endothelial dysfunction in 3D engineered vascular networks

B Stern, P Monteleone, J Zoldan - Journal of Biomedical …, 2024 - Wiley Online Library
With new daily discoveries about the long‐term impacts of COVID‐19, there is a clear need
to develop in vitro models that can be used to better understand the pathogenicity and …